Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...
More than a decade ago, Addyi—marketed as the “female Viagra”—was approved amid political pressure, heavy lobbying, and a lot ...
The FDA expanded its approval of Addyi, a pill to treat low libido in women, to include postmenopausal women up to age 65. The approval will open up new treatment options for older women, but experts ...
On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved ...
WASHINGTON -- The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to ...
IRVINE, CA – July 5, 2023 – The Ad Firm is thrilled to announce the publication of an abstract by Sprout Pharmaceuticals, showcasing the remarkable effects of Addyi (flibanserin) on low libido among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback